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ABSTRACT
Introduction: Meningococcal colonization, or
carriage, can progress to invasive meningococ-
cal disease, a serious public health concern,
with rapid progression of disease and severe
consequences if left untreated. Information on
meningococcal carriage and epidemiology in
low/middle income American and Asian coun-
tries remains sparse. These data are crucial to
ensure that appropriate preventive strategies
such as vaccination can be implemented in
these regions. The goal of this study was to
summarize the Neisseria meningitidis carriage
literature in low and middle income countries
of the Americas and Asia.
Methods: Target countries were categorized as
low and middle income according to the Inter-
national Monetary Fund classification of low
income/developing economies and middle
income/emerging market economies, respec-
tively. A PubMed search identified English-
language publications that examined carriage in
these countries. Studies reporting the epidemi-
ology of N. meningitidis carriage or assessing risk
factors for carriage were included.
Results: Fourteen studies from the Americas
[Brazil (n = 7), Chile (n = 3), and Colombia,
Cuba, Mexico, and Paraguay (n = 1 each)] and
nine from Asia [China (n = 2), India (n = 3), and
Malaysia, Nepal, Philippines, and Thailand
(n = 1 each)] were identified; an additional
Cuban study from the authors’ files was also
included. Studies were not identified in many
target countries, and substantial diversity was
observed among study methodologies, popula-
tions, and time periods, thereby limiting com-
parison between studies. The carriage rate in the
Americas ranged from 1.6% to 9.9% and from
1.4% to 14.2% in Asia. Consistent risk factors
for carriage were not identified.
Conclusions: There is a lack of comprehensive
and contemporary information on meningo-
coccal carriage in low and medium income
countries of the Americas and Asia. Future
Digital Features To view digital features for this
article go to https://doi.org/10.6084/m9.figshare.
11962566.
Electronic supplementary material The online
version of this article (https://doi.org/10.1007/s40121-
020-00291-9) contains supplementary material, which is
available to authorized users.
L. Serra (&)
Pfizer Vaccine Medical Development, Scientific and
Clinical Affairs, Collegeville, PA, USA
e-mail: Lidia.Oliveira@pfizer.com
J. Presa
Pfizer Vaccines, Medical and Scientific Affairs,
Collegeville, PA, USA
H. Christensen
Bristol Medical School, Population Health Sciences,
University of Bristol, Clifton, UK
C. Trotter
Department of Veterinary Medicine, University of
Cambridge, Cambridge, UK
Infect Dis Ther
https://doi.org/10.1007/s40121-020-00291-9
carriage studies should incorporate larger rep-
resentative populations, a wider age range, and
additional countries to improve our under-
standing of meningococcal epidemiology and
disease control.
Keywords: Asia; Carriage; Latin America;
LMICs; Neisseria meningitidis
Key Summary Points
Why carry out this study?
Meningococcal colonization, or carriage,
can progress to invasive meningococcal
disease, a serious public health concern,
with rapid progression of disease and
severe consequences if left untreated.
Meningococcal carriage and epidemiology
in low/middle income American and
Asian countries is unclear, thus presenting
a barrier to implementing effective
vaccination strategies.
The goal of this study was to summarize
the Neisseria meningitidis carriage literature
in low andmiddle income countries of the
Americas and Asia.
What was learned from the study?
Reported carriage prevalence was 1.6–9.9%
in the Americas and 1.4–14.2% in Asia.
Risk factors for carriage were inconsistent
between studies.
Comprehensive regional carriage studies
are needed to improve disease control.
INTRODUCTION
Invasive meningococcal disease (IMD) is caused
by infection by the Gram-negative bacterium
Neisseria meningitidis [1]. Globally, the incidence
and mortality from meningococcal meningitis
has been decreasing since 1990, although dis-
parities persist regarding at-risk age groups and
geographic distribution [2]. In 2017, more than
400,000 cases and nearly 30,000 deaths were
attributed to meningococcal meningitis [3].
IMD has a characteristically rapid course; fatal-
ities often occur within 24 h [1, 4]. Additionally,
approximately one in five survivors of IMD have
long-term and disabling sequelae [5].
Nearly all life-threatening IMD is
attributable to six serogroups (A, B, C, W, X, Y)
[1]. IMD incidence and the most prevalent
disease-causing serogroups vary by age group, as
well as geographically and temporally [6]. For
instance, meningococcal serogroup A (MenA)
has predominated in sub-Saharan Africa and
Southeast Asia and meningococcal serogroup B
(MenB) and serogroup C (MenC) have pre-
dominated in South America [6]. MenB is also
the predominant disease-causing serogroup in
several Western countries and regions [7, 8].
During the past 5–10 years, considerable
increases in IMD caused by meningococcal ser-
ogroup W (MenW) have been observed within
several regions, including South America, Eur-
ope, Australia, and New Zealand [8, 9].
The ecological niche of N. meningitidis is the
human nasopharynx [1]. Transmission of N.
meningitidis through respiratory secretions does
not always result in disease; this asymptomatic
colonization of the mucosa of the upper respi-
ratory tract is a phenomenon known as carriage.
Acquisition of meningococci usually results
from close contact with a carrier rather than
directly from a patient with IMD, highlighting
the importance of carriage in IMD epidemiol-
ogy [10–12]. In high-income regions such as the
United Kingdom, carriage acquisition is highest
in adolescents and young adults [13]. In a recent
longitudinal study of the acquisition of
meningococcal carriage in sub-Saharan Africa,
the highest carriage rates were in those aged
5–14 years [12]. Based on data from North
America, Europe and Australasia, carriage is
associated with behaviors common in adoles-
cents and young adults, such as living in dor-
mitories, patronizing bars, smoking, and
sharing utensils or beverages [14–16]. Because
most transmission occurs between carriers,
using effective preventive strategies, such as
vaccination, is important to decrease carriage
rates in a population through both direct
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vaccination and herd effect, as has been illus-
trated by the use of meningococcal conjugate
vaccines [17–19].
The lack of comprehensive data available
for carriage, particularly in low and middle
income countries outside of sub-Saharan
Africa, limits elucidation of the epidemiology
of IMD and carriage. These data are required
to ensure that appropriate preventive strate-
gies are implemented. The purpose of this
review is to summarize the current literature
regarding the carriage of N. meningitidis in
low and middle income countries of the
Americas and Asia. These data could inform
healthcare authorities of regional disease
burden and potentially influence existing
meningococcal vaccination policies (summa-
rized in Table S1).
METHODS
Low income/developing and middle income/
emerging market economies of the Americas
and Asia were identified according to the
International Monetary Fund classification
(hereafter referred to as low and middle income
countries, respectively) [20]. A PubMed search
was conducted on November 11, 2019, of
English-language publications from 1980 that
examined carriage in low and middle income
countries of the Americas (i.e., South America,
Latin America, and the Caribbean) and Asia
utilizing the search strings summarized in
Table 1. Studies reporting the epidemiology of
carriage, including overall, by serogroup, and by
age group and/or assessing risk factors for car-
riage were included in the analysis. Any rele-
vant articles from authors’ files were also
included. Narrative and systematic reviews,
conference proceedings, and case studies were
excluded and the reference lists of the identified
studies were not systematically reviewed to
identify other published studies. This article is
based on previously conducted studies and does
not contain any studies with human partici-
pants or animals performed by any of the
authors.
Table 1 PubMed search strings
Region of Interest PubMed search string
The Americas (South America, Latin
America, and the Caribbean)
(Neisseria meningitidis OR N meningitidis) AND (carriage OR colonization
OR colonisation OR carrier) AND (Antigua OR Argentina OR Barbuda
OR Bahamas OR Barbados OR Belize OR Bolivia OR Brazil OR Costa
Rica OR Chile OR Colombia OR Dominica OR Dominican Republic OR
Ecuador OR El Salvador OR French Guiana OR Grenada OR Grenadines
OR Guatemala OR Guyana OR Guiana OR Haiti OR Honduras OR
Jamaica OR Mexico OR Nevis OR Nicaragua OR Panama OR Paraguay
OR Peru OR St Kitts OR St Lucia OR St Vincent OR Suriname OR
Trinidad OR Tobago OR Uruguay OR Venezuela OR South America OR
Latin America OR Caribbean)
Asia (Neisseria meningitidis OR N meningitidis) AND (carriage OR colonization
OR colonisation OR carrier) AND (Bangladesh OR Bhutan OR Brunei
OR Brunei Darussalam OR Burma OR Cambodia OR China OR Fiji OR
India OR Indonesia OR Kiribati OR Laos OR Malaysia OR Maldives OR
Marshall Islands OR Micronesia OR Mongolia OR Myanmar OR Nauru
OR Nepal OR Palau OR Papua New Guinea OR Philippines OR Samoa
OR Solomon Islands OR Sri Lanka OR Thailand OR Timor-Leste OR
Tonga OR Tuvalu OR Vanuatu OR Vietnam)
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For each identified publication, data regard-
ing the population, setting, time frame, and
epidemiology of carriage were extracted
(Tables 2, 3). Additionally, the source and
methodology to determine carriage were sum-
marized (Tables S2, S3). As carriage should be
considered in the context of disease epidemi-
ology and vaccination strategies, a narrative
review of these factors in the relevant regions
and countries identified in this literature search
has also been included.
RESULTS
The Americas
Surveillance, Disease, and Vaccination
The epidemiology of meningococcal disease
and carriage in Latin America is not well char-
acterized, which is largely attributed to dispari-
ties in surveillance activities between countries.
Much of the data are obtained through a
surveillance network system, which includes
regional reference laboratories [19]. Although
notification of IMD is compulsory in Latin
America [21], the data are mainly passive, and
only a few countries provide systematic and
detailed reporting [22]. Thus, the quality of the
reported data is often poor. Additionally,
notable differences exist in healthcare systems,
diagnostic methods, and the case definitions of
IMD that may lead to great variability in epi-
demiologic data between countries [21].
The annual incidence of IMD in Latin
America also varies widely between countries
[21]. Currently, most cases of IMD in Latin
America are sporadic and commonly caused by
MenB and MenC, with the emergence of MenW
in countries of the Southern Cone [21]. MenA
disease is rarely observed in Latin America.
Infants and young children in Latin America are
particularly susceptible to sporadic cases of
IMD, and adolescents and young adults are
notably affected during outbreaks.
Meningococcal vaccines have not typically
been included in national immunization pro-
grams in Latin America; rather, the use of
meningococcal vaccination has often been in
response to mass vaccination campaigns to
control outbreaks and epidemics [23]. However,
there are exceptions (Table S1) [24]. For
instance, in 2010, Brazil introduced a MenC
vaccine into their national immunization pro-
gram in response to an increased incidence of
IMD among infants and young children and
recurring outbreaks throughout the country
[25, 26]. The vaccine was administered at age 3
and 5 months, with a booster dose given at age
12–15 months. Toddlers aged 12–23 months
received one dose of the vaccine. No catch-up
vaccination for older age groups was provided at
that time [23]. Regional vaccination campaigns
have also been conducted in Brazil. For exam-
ple, the MenC vaccine was administered to
individuals aged 10–24 years in the city of Sal-
vador between May and August 2010 in
response to an increased IMD burden in this age
group in the first semester of the 2010 school
year [27].
In addition, disease caused by MenW began
to increase in Chile in 2010, accounting for 58%
of all cases by 2012 [28]. This was a hyperviru-
lent strain often attributed to sequence type 11
clonal complex (cc11) [21], which caused an
increase in mortality and long-term disabling
sequelae [28]. The incidence rate was highest in
very young infants, with a second peak
observed in older adults (aged[60 years); the
number of cases of MenW disease in adolescents
was very low [21]. A mass vaccination campaign
with a meningococcal quadrivalent vaccine was
accordingly implemented by the Chilean Min-
istry of Health in October 2012 for children
aged 9 months to 5 years, followed by the
introduction of the meningococcal quadriva-
lent conjugate vaccine (MenACWY) into rou-
tine vaccination schedules at 12 months of age
in 2014 [21, 28–31].
Similar to the experience in Chile, Argentina
observed an increase in MenW disease preva-
lence around 2008, with the sequence type cc11
accounting for 78% of all MenW strains [9].
From 2012 to 2015, MenW was responsible for
nearly half of all meningococcal disease cases
across all ages, particularly among infants
aged\9 months. In early 2017, Argentina
introduced MenACWY into the national
immunization plan for infants
aged[3 months, with two doses at ages 3 and
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5 months, respectively, followed by a booster at
age 15 months. A single dose of the vaccine was
also recommended for adolescents to reduce
carriage rates. Surveillance of the impact of
including MenACWY in the national immu-
nization plan is still ongoing because of the
program’s recency.
In 1989, individuals aged 3 months to
24 years in Cuba were vaccinated with a com-
bined MenB and MenC vaccine (VA-MENGOC-
BC) because of an increased incidence of disease
predominantly attributed to a single MenB
clone (strain CU385) [32]. Importantly, vacci-
nation resulted in a notable decrease in disease
incidence from a peak of 14.4 cases per 100,000
population in 1983–1984 (before vaccine
inclusion in the vaccination program) to\ 0.4
cases per 100,000 population in 2001, and 0.1
cases per 100,000 population in 2008.
Literature Search Findings on Carriage
in the Americas
The literature search identified 52 publications
from the Americas (Fig. 1). Of these, 14 met the
inclusion criteria and were included in the
review, including seven studies from Brazil
[33–39], three from Chile [40–42], and one each
from Colombia [43], Cuba [32], Mexico [44],
and Paraguay [45] (Fig. 2; Table 2). An addi-
tional non-English language publication from
Cuba from the authors’ files was included [46].
No studies from Central America or the Car-
ibbean were identified. Because different labo-
ratory methods can affect carriage assessments,
the methodology used to ascertain carriage and
the source of the isolates within these studies
have been summarized (Table S2).
Brazil
Seven studies reporting carriage in Brazil were
identified. The most recent data were from two
separate publications of the same sample. From
September to December 2014, Nunes and col-
leagues assessed the meningococcal carriage of
1200 students aged 11–19 years enrolled in 134
municipal or state public schools in Salvador
[33]. Participants were selected by a two-stage
probabilistic method in which 155 schools were
initially randomly selected and weighted
according to the probability of school selection
by the proportion of students in each of the
schools in Salvador. The final stage was
Fig. 1 Literature search results. Asterisk articles that did
not meet the inclusion criteria or that fulfilled the
exclusion criteria were excluded. Dagger one additional
study from the authors’ files was included for a total of 15
studies included in this analysis
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selection of 134 of the 155 randomly selected
schools that provided student names. The
overall carriage rate was 4.9% (59/1200).
Bivariate analysis found the following signifi-
cant risks for carriage: having only 1 room for
sleeping (2.02 prevalence ratio; P = 0.05),
Fig. 2 Summary of literature search results and carriage
rates by country in the Americas. Carriage rates are
indicated in italics. Additional information on study design
and population is provided in Table 2 and Table S2.
Asterisk carriage rates not reported in identified study.
Dagger does not include carriage rates from outbreaks or
related to invasive meningococcal disease cases or their
contacts. Population age ranges: a\ 5 years (attending
daycare) and 15–19 years (living in social rehabilitation
centers or students); b 15–21 years (students); c 11–19
years (students); d 11–19 years (students); e 3–21 years
(health center attendees and students); f 18–24 years
(students); g 10–19 years (hospitals and schools)
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having only mothers who smoke (2.48 preva-
lence ratio; P = 0.01), and attending a pub or
party C 5 times per month (2.61 prevalence
ratio; P = 0.02). Multivariable analyses were not
conducted. Moura and colleagues later charac-
terized the 59 carriage isolates by serogroup and
multilocus sequence typing (MLST) [34]. The
majority of isolates were nongroupable (61.0%;
36/59). The most common groupable isolates
were MenB (11.9%; 7/59), MenY (8.5%; 5/59),
MenE (6.8%; 4/59), MenZ (5.1%; 3/59), MenC
(3.4%; 2/59), and MenW (3.4%; 2/59); no MenA
or MenX carriage isolates were identified. Of the
34 different sequence types identified, the most
frequent were cc1136 (35.3%; 12/34) and cc198
(32.4%; 11/34). Hyperinvasive lineage com-
plexes were also identified, the most common
being cc23 (6.8%; 4/59) and cc41/44 (5.1%;
3/59). The authors postulated that the low rate
of MenC carriage isolates was likely attributed
to the mass MenC vaccination campaign for
subjects aged 10–24 years conducted in Salvador
in 2010, as described above.
Cassio de Moraes and colleagues assessed
meningococcal carriage in 1208 students aged
11–19 years attending 73 schools in Campinas
over a 3-month period (May–July, 2012) [35].
This period covers postimplementation of the
MenC national immunization program in
infants in 2010 described above. Public and
private schools were randomly selected from
the five health districts in Campinas according
to the number of students in each grade corre-
sponding to the age groups in the study. Par-
ticipants from the selected schools were
randomly chosen, and included up to five stu-
dents from each class. The overall carriage rate
in this sample was 9.9% (120/1208). The most
common serogroups were MenC (13.4%;
16/120), MenB (10.0%; 12/120), MenE (7.5%;
9/120), MenY (5.0%; 6/120), MenW (2.5%;
6/120), and MenZ (0.8%; 1/120); the majority of
isolates were nongroupable (60.8%; 73/120). By
MLST, 36 sequence types were identified, with
the most common being cc53 (41.7%; 15/36)
and cc1136 (33.3%; 12/36). Univariate analysis
identified a significant increase in the percent-
age of carriers among type of school attended
(11.3% public school vs. 5.8% private school;
v2 = 7.834, P = 0.005), recent influenza-like
illness (12.7% yes vs. 8.5% no; v2 = 5.090,
P = 0.024), night club attendance (13.8% yes vs.
5.8% no; v2 = 15.768, P\ 0.001), passive
smoking (13.2% yes vs. 8.4% no; v2 = 6.670,
P = 0.010), vaccination status with MenC
polysaccharide or conjugate vaccine (5.2% yes
vs. 10.5% no; v2 = 5.165, P = 0.023), and par-
ental level of educational attainment (13.2%
none vs. 10.3% fundamental vs. 10.4% basic vs.
5.6% high; v2 = 8.787, P = 0.032). Multivariable
analyses indicated that only parental education
level, specifically a lower level of education, was
a significant risk factor independently associ-
ated with carriage risk (odds ratio, 2.14;
P = 0.022).
From October 2011 to May 2012, Weckx and
colleagues assessed carriage from a sample of
87 individuals aged 1–24 years recruited from
six basic healthcare units and three schools in
the Embu das Artes region of Sa˜o Paulo; addi-
tional details regarding participant recruitment
were not provided [36]. The study covered the
period 10 months after introduction of the
MenC vaccine in the national immunization
program, as described above. The overall car-
riage rate was 9.0% (87/967), with higher rates
in younger (10–14 years; 12.5%) and older
adolescents (15–19 years; 12.6%). Higher rates
of carriage were observed among unvaccinated
versus MenC-vaccinated subjects (8.5% vs.
4.8%). The most common disease-associated
serogroups were MenC (18.4% of all N. menin-
gitidis carriage isolates identified) and MenB
(12.6%); MenB carriage was most common in
young adults (aged 20–24 years; 23.1%), MenC
in older adolescents (aged 15–19 years; 37.5%),
and MenY in children (aged 5–9 years; 11.1%).
The majority of carriage isolates were non-
groupable (60.9%), and no MenA carriage iso-
late was identified. Logistic regression analysis
showed the number of household members was
independently associated with increased risk of
meningococcal carriage in the 15–19 years age
group (odds ratio, 1.35; P = 0.019).
Coch Gioia and colleagues assessed oropha-
ryngeal samples of 100 employees and 100 stu-
dents aged 20–60 years from a university
hospital in Rio Grande do Sul State in 2011,
which also covered the period after inclusion of
the MenC vaccine in the national
Infect Dis Ther
immunization program [37]. The overall car-
riage rate was 9% (18/200). Carriage was signif-
icantly higher in men than women (16.7% vs.
5.7%; P = 0.013). Other significant risk factors
for carriage were bar attendance (88.9% vs.
53.8% in carriers vs. noncarriers; P = 0.004), bar
attendance frequency (72.2% vs. 42.8% for 1–2
times monthly, 16.6% vs. 11.5% for C 3 times
monthly; P = 0.01), mean age (26.5 vs. 33.3
years; P = 0.02), and mean number of house-
hold members (1.94 vs. 2.66; P = 0.04); multi-
variable analyses were not described.
Assessment of antibiotic sensitivity indicated
that 13 of the carriage strains were sensitive to
all tested antibiotics, and four were of interme-
diate sensitivity to penicillin and two to
ampicillin.
MenC outbreaks occurred in two oil refiner-
ies in 2010 in Sa˜o Paulo State, with a mass
vaccination program with a combined MenA
and MenC polysaccharide vaccine conducted in
one of the refineries that achieved 91% vaccine
uptake [38]. Safadi and colleagues described
meningococcal carriage in a sample of 483
workers from these two refineries from
March 29 to June 30, 2010; the method of
choosing the selected participants was not
described [38]. The overall carriage rate was
21.5% (104/483), and the carriage rate was
comparable in both refineries (21.4% vs. 21.6%)
even though the vast majority of workers in
only one of the refineries had been vaccinated.
Of the 56 serogrouped carriage samples, the
most common was MenC (48.2%; 27/56); less
frequently observed serogroups were MenB
(16.1%; 9/56), MenE (14.3%; 8/56), MenY
(12.5%; 7/56), and MenW (8.9%; 5/56). Among
the 27 isolates characterized by MLST (14 in the
refinery that had received vaccination; 13 in the
refinery that had not), the most common clonal
complex was cc11 (28.6%; 4/14) in the refinery
that had received vaccination and cc103
(46.2%; 6/13) in the refinery that had not. The
only significant risk factor for carriage was not
completing secondary education (32.9% among
carriers vs. 19.2% among noncarriers; P = 0.01).
The authors postulated that less educated
workers in oil refineries were more likely to
perform duties requiring use of ear protection
that could force close contact during
conversation and thereby facilitate meningo-
coccal transmission.
Barroso and colleagues reported differences
in carriage rates at hospital admission and after
discharge for 55 patients with meningococcal
disease as well as among close contacts who
received chemoprophylaxis for 10 days [39].
The study was conducted at the Sa˜o Sebastia˜o
State Institute in Rio de Janeiro over a period of
8 months, but the specific dates of the study
were not reported. The carriage rate was 62%
(34/55) at admission and 4% (2/55) at dis-
charge. No nasopharyngeal carriage isolates
were identified in close contacts of patients.
Chile
Three studies from Chile assessed carriage. The
most recently published was a study by Rubilar
and colleagues on the correlation of IMD ser-
ogroups with meningococcal carriage ser-
ogroups in children and adolescents aged
9–19 years [40]. The study included 184 carriage
samples from children and adolescents and 119
invasive samples from all ages obtained from
the national reference laboratory. The carriage
isolates were specifically obtained from three
regions (Metropolitana, Valparaı´so, and Bio-
Bı´o) from April to June 2013 (i.e., the period
after the MenACWY vaccination program
described above). It was not specified by the
authors whether the sample included all car-
riage samples obtained during that period and
from the three regions. MenB was the most
common carriage isolate (40% of carriers) fol-
lowed by nongroupable (26%), MenC (18%),
and MenW (5%). Although similar percentages
of isolates between MenB carriage and disease
isolates were found (40% vs. 32%), a similar
effect was not observed for nongroupable (26%
vs. 0%), MenC (18% vs. 2%), or MenW (5% vs.
66%) isolates. Because of the emergence of the
hypervirulent MenW cc11 strain within the
country, the assessment of carriage and disease
isolates by clonal complex was undertaken. It
was found that MenW cc11 was predominant
among disease isolates (66%). However, carriage
isolates demonstrated a higher diversity of clo-
nal complexes, with cc41/44 being
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predominant and with only 5% of carriage iso-
lates attributed to cc11.
Also, from Metropolitana, Valparaı´so, and
Bio-Bı´o in 2013 (April–July), Diaz and col-
leagues collected 4217 posterior pharynx speci-
mens of children and adolescents aged
10–19 years from 19 hospitals as well as from
15 university campuses and 56 schools located
close to the selected hospitals [42]. All individ-
uals matching the selection criteria were asked
to participate (i.e., healthy male and female
subjects aged 10–19 years who provided consent
to participate, had no history of IMD or chronic
diseases, were not using immunosuppressants
or antibiotics in the past month, and had not
received previous meningococcal vaccination).
The overall carriage rate was 6.5% (272/4217).
The most prevalent serogroup was MenB (1.7%)
and nongroupable (3.0%). The prevalence of
MenC, MenW, MenY, and MenZ was B 0.8%.
Univariate analysis found a significant associa-
tion of carriage with age (mean 14.22 years for
carriers vs. 13.77 years for noncarriers;
P = 0.009), number of intimate kissing partners
in the past 30 days (mean 0.60 vs. 0.46;
P = 0.044), and attending crowded events in
closed spaces (49% vs. 37%; P = 0.008). Multi-
variable regression analysis found a significant
7.7% increased risk of carriage per year of age
(P = 0.002) and that the number of children in
the household increased the risk by 18% per
child (P = 0.02); however, no association of
carriage with factors associated with over-
crowding or geography was found. For children
younger than 14 years, exposure to tobacco in
the household was linked to a significantly
decreased risk of carriage in multivariable
regression analysis; however, a significantly
increased risk of carriage was observed for those
living in households with more smokers or
more children. Conversely, individuals 14 years
or older who were exposed to tobacco in the
household had a significantly increased risk of
carriage, and females had a significantly
decreased risk of carriage.
The third study from Chile was by Rodriguez
and colleagues and included 500 healthy uni-
versity students in Santiago aged 18–24 years
[41]. Participants who had previous meningo-
coccal disease, chronic diseases, or reported
antibiotic use in the previous month were
excluded; other approaches to selecting partic-
ipants were not described. The time the samples
were collected (October 2012) corresponded
with the increase in MenW cc11 cases described
above. The overall carriage rate was 4% (20/
500), with 20% (4/20) of carriage isolates being
MenB, 15% (3/20) MenW, and the rest being
noncapsulated (65%; 13/20). Of the eight iso-
lates in which a clonal complex could be
assigned, the most commonly observed were
cc41/44 (37.5%; 3/8) and cc175 (25.0%; 2/8).
The only risk factor found to be significantly
associated with carriage was sharing a room
(25% of carriers vs. 15% of noncarriers;
P = 0.02); a trend for pub attendance in the
previous month was observed as a risk factor for
carriage (85% vs. 63%; P = 0.05). No statistically
significant differences were seen between carri-
ers and noncarriers in univariate analysis.
Unlike the findings by Rubilar and colleagues
[40], none of the MenW carriage isolates were
attributed to cc11 [41].
Colombia
One study assessed meningococcal carriage in
Colombia. Moreno and colleagues reported the
prevalence of meningococcal carriage of stu-
dents in Bogota´ in a 3-month period in 2012
(August–October) [43]. All adolescents in the
ninth to eleventh school grades were invited to
participate, and those whose parents provided
written consent for participation were included,
as were consenting healthy university students.
The study included 1459 students aged 15–
21 years from 12 secondary schools and seven
universities. The overall carriage rate was 6.9%
(100/1459); the highest carriage rates were in 20
(4.6%) and 21 year olds (7.0%) and the lowest in
18 (2.5%) and 19 year olds (3.2%). The most
common serogroups were MenY (22%; 22/100)
and MenB (15%; 15/100). MLST analysis of
74 isolates was undertaken; the most common
clonal complexes were cc23 (21.6%; 16/74),
cc53 (17.6%; 13/74) and cc198 (13.5%; 10/74).
A Chi square analysis found a statistically sig-
nificant difference in carriage among those who
engaged in oral sex (odds ratio, 1.70; P = 0.030),
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but no significant effect of sex, intimate kissing,
social venue attendance, cigarette smoke expo-
sure, bedroom sharing, biomedical science stu-
dents, respiratory infection, and antibiotic
consumption in the previous month was found.
Notably, a multilevel stratified analysis adjusted
for sex, intimate kissing, social venue atten-
dance, bedroom sharing, and smoking showed
that the risk of carriage in those who engaged in
oral sex was not significantly different from
those who did not.
Cuba
One study by Climent and colleagues assessed
the distribution of disease and carriage isolates
by meningococcal serogroups from Cuba
between 1983 and 2005 [32]. The authors
undertook the present analysis, which covered
the periods before and after the introduction of
VA-MENGOC-BC as described above, to under-
stand the effect of the mass vaccination cam-
paign on disease and carriage. Individuals
receiving antimicrobial therapy in the past
7 days before sampling or receiving any
immunomodulatory treatment were excluded.
A total of 167 disease and 253 carriage samples
from across Cuba were included, and the car-
riage isolates were obtained from healthy chil-
dren aged 0–12 years and from adolescents and
young adults aged 14–22 years who were
attending schools at the time of recruitment
Fig. 3 Summary of literature search results and carriage
rates by country in Asia. Carriage rates are indicated in
italics. Additional information on study design and
population is provided in Table 3 and Table S3. Asterisk
identified studies did not report carriage rates outside of an
outbreak setting. Dagger does not include carriage rates
related to invasive meningococcal disease cases or their
contacts. Population age ranges, a 5–14 years (students); b
6–20 years (students); c 16–25 years (military recruits); d
5–15 years (students); e 17–24 years (military recruits); f
5–24 years (students)
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(i.e., kindergartens, primary schools, high
schools, military schools, or universities). MenB
accounted for 43.9% of carriage isolates (111/
253), and no MenC carriage isolate was identi-
fied. Other carriage strains included non-
groupable (31.2%; 79/253), MenW (0.8%;
2/253), and MenZ (0.4%; 1/253). Of the 63
sequence types identified by MLST, the most
common was cc32 (11.1%; 7/63). Notably, in
the period after the epidemic, the specific MenB
epidemic strain observed among carriage iso-
lates significantly decreased, while strains not
associated with epidemic outbreaks emerged.
A Spanish-language publication by Martinez
Motas and colleagues that was obtained from
the authors’ files provides additional insights
regarding the meningococcal isolates observed
during and after the epidemic [47]. Among
isolates collected in Cuba from healthy carriers
during the epidemic period (1982–1992;
n = 105 isolates), MenB (67.6%), serotype 4
(70.5%), and subtype P1.19,15 (61.9%) pre-
dominated [32, 47]. In contrast, during the
postepidemic period following VA-MENGOC-
BC vaccination (1993–2002; n = 226 isolates),
nonserogroupable (NG; 79.7%), nonserotypable
(NT; 70.8%), and nonserosubtypable (NST;
35.0%) strains were most common [47]. Overall,
the predominant carriage phenotype during the
epidemic was B:4:P1.19,15, while
NG:NT:P1.NST was predominant in the post-
epidemic period.
Mexico
One publication assessed carriage in Mexico.
Espinosa de los Monteros and colleagues
reported the epidemiology of N. meningitidis
carriage isolates in children younger than
5 years and adolescents in Mexico City from
September 2004 to April 2005 [44]. Using a non-
probabilistic group sampling method from the
healthy population, investigators studied chil-
dren attending daycare centers (n = 736) and
adolescents in social rehabilitation centers
(n = 774) or attending universities (n = 800);
2310 nasopharynx swabs were obtained from
these individuals. The overall carriage rate was
1.6% (37/2310), with the greatest rate observed
in adolescents living in social rehabilitation
centers (2.9%; 23/774) and in children attend-
ing daycare centers (1.9%; 14/736). No carriage
isolates were identified from university stu-
dents. The most frequent carriage serogroups
were MenY (29.7%), MenC (24.3%), and MenB
(10.8%). Nontypeable isolates accounted for
27.0% of carriage isolates.
Paraguay
One study evaluated carriage in Paraguay in
individuals aged 3–21 years between March
2011 and December 2012 [45]. Children were
recruited from four health services and indi-
viduals aged 6–21 years were recruited from
schools and universities from Asuncio´n and the
surrounding areas. A total of 2011 oropharyn-
geal swabs were obtained. The overall carriage
rate was 2.1%, with no significant differences
demonstrated by sex, age group, or area of res-
idence. Genogrouping revealed that 26.0% of
strains were MenB, 9.0% were MenW, 6.0%
were MenY and 6.0% were MenC. Overall,
61.9% of carriage isolates were nontypeable.
The small sample size precluded inference of
risk for meningococcal carriage (i.e., close
habitation, respiratory infection, and smoking
and vaccination status).
Asia
Surveillance, Disease, and Vaccination
Currently, low and middle income countries in
Asia do not have routine and robust IMD
surveillance programs; therefore, disease burden
and at-risk populations are not well elucidated
[19, 48]. In addition, few countries in the region
currently include meningococcal vaccines in
their national immunization programs
(Table S1) [24].
Because of limited data, the epidemiology of
IMD in Asia is uncertain, although the disease
burden is unlikely to be large due to the nature
of meningococcal disease. It appears that MenA
and MenC may predominate, although reports
of MenW disease have become more frequent in
several countries [49]. A total of 292 IMD cases
were reported in Taiwan during 1996–2002,
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with the majority of confirmed cases due to
MenB and MenW [50]. MenA was the predom-
inant cause of IMD in China from the 1950s to
the 1980s [51], but after the introduction of
MenA vaccination using a polysaccharide vac-
cine, an increase in MenC disease was observed
[49, 51]. More recently, cases due to MenB and
MenW have also increased [49]. Although
reported cases of meningitis due to IMD have
decreased in India since 2002, the number of
reported IMD outbreaks has increased; since
2005 there have been three significant out-
breaks, all caused by MenA [49, 52]. In the
Philippines, data collected during 2008–2013
showed an increase in cases of meningococ-
cemia (73 and 182 cases in 2008 and 2013,
respectively); these cases most commonly
occurred in infants and young children and
were mostly due to MenA [49].
Literature Search Findings on Carriage in Asia
The literature search identified 49 publications
from Asia (Fig. 1). Of these, nine met the
inclusion criteria and were included in the
review, including two studies from China
[51, 53], three from India [54–56], and one each
from Malaysia [57], Nepal [58], the Philippines
[48], and Thailand [59] (Fig. 3; Table 3). Because
different laboratory methods can affect carriage
assessments, the methodology used to ascertain
carriage within these studies is summarized
(Table S3).
China
Two studies from China assessed meningococ-
cal carriage. The first study was conducted in
Jinan City in 2010 at the time of a MenC disease
outbreak in three young adult male prisoners.
Zhang and colleagues determined the point
prevalence of meningococcal carriage in
166 fellow prisoners, 16 of whom shared the
same cell as the IMD patients [53]. N. meningi-
tidis was isolated from pharyngeal swabs of 10 of
the 16 cellmates (carriage rate 62.5%). These
isolates included six MenC, one MenB, one
MenW, and two nongroupable strains. Of the
150 other fellow inmates sampled, 37 were
found to be carriers, with isolates including
23 MenC, nine MenB, two MenA, one MenY, and
two nongroupable strains (carriage rate 24.6%).
The carriage rate was significantly higher in cell-
mates of the patients compared with non-cell-
mates, both over all strains (P\0.01) and for the
MenC cc4821 clone associated with the outbreak
(37.5% vs. 13.3%; P\0.05).
In the second study, Zhou and colleagues
analyzed 241 meningococcal strains isolated
from throat swabs of asymptomatic carriers
across 22 provinces in China during 2003–2008
(these provinces have laboratories that rou-
tinely collect N. meningitidis isolates). The
analysis revealed a predominance of MenC
(62.2%), MenB (19.5%), and MenA isolates
(9.5%), low frequencies of MenW, MenZ,
MenX, and Men29E isolates (B 1.2% each), and
a moderate frequency of nongroupable isolates
(6.2%) [51]. The study also characterized
130 disease isolates collected during the same
time period; of these, 58.5% were MenC and
34.6% were MenA, whereas MenB accounted for
only 3.9%. cc5 and cc4821 were the most
commonly occurring clonal complexes in both
disease and carriage isolates, cc5 being associ-
ated with most MenA isolates (94.1%) and
cc4821 with most MenC isolates (87.6%).
However, because some of the carriers in this
study were associates of IMD cases, the study’s
findings may not accurately represent normal
carriage.
India
Three studies from India assessed carriage. The
most recently published was a meningococcal
carriage study by Jha and colleagues conducted
in 1995 in military recruits in India which
investigated a range of risk factors potentially
associated with carriage [54]. The overall car-
riage rate in throat swabs obtained over a
3-month period from 360 new recruits aged
16–25 years was 11.9%. The highest carriage
rate was observed among recruits from the
eastern region (18.0%) and the lowest was
among those from the central region (4.7%) of
the country. A significantly higher (P\ 0.05)
carriage frequency was identified in recruits
from joint families (14.4%) compared with
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those from nuclear families (7.4%); it was sug-
gested that this difference may be because of the
overcrowded living conditions frequently asso-
ciated with a joint family, and further noted
that this family structure is more common
among lower socioeconomic classes in India.
Although carriage rate increased with age and
was higher among recruits previously living in
mud houses compared with those previously
living in concrete houses (15.2% vs. 9.8%),
neither of these associations was statistically
significant. Religion, education, level of per-
sonal hygiene, smoking, barrack type, upper
respiratory tract infection, and previous tonsil-
lectomy also showed no significant association
with the carriage state.
The second study from India was by Ichh-
pujani and colleagues, who, during January
1986 to December 1987, collected nasopharyn-
geal samples from 6513 healthy students aged
6–20 years living in various locations across
Delhi [55]. Most of the students sampled
belonged to middle or lower income strata;
further clarification regarding the participant
selection was not provided. Overall, N. menin-
gitidis was isolated from 1.6% (107/6513) of
subjects, with no observed differences in car-
riage rate by age or sex. During the same time
period, 4.7% (557/11870) of pyogenic cere-
brospinal fluid samples processed in six sentinel
laboratories in Delhi were positive for N.
meningitidis. All carriage and disease isolates
were MenA, although no correlation between
carriage rates and disease prevalence was
identified.
A third study carried out in India examined
the carriage rate among contacts of 11 index
patients diagnosed with invasive MenA disease
during March to June 1985 in Delhi [56]. Paul
and colleagues evaluated 272 contacts, 53 of
whom were family/household contacts and 219
of whom were neighbors or schoolmates of an
index case. Nasopharyngeal swabs were initially
obtained from contacts within 96 h of the index
patient being admitted to the hospital; in the
second phase of the study, 130 contacts with
initially negative cultures were resampled 2–
4 weeks later. In total, 402 swabs from 272
contacts were processed. Individuals older than
14 years made up 56.2% of contacts, and just
over half were male (54.4%). None of the con-
tacts sampled had received previous chemo-
prophylaxis or vaccination against
meningococcal disease. N. meningitidis was cul-
tured from three of the 272 initial swabs; all
three isolates were MenA strains and collected
from family/household contacts. Subsequently,
the carriage rate at the time of the first sampling
was just 1.1% (3/272) among all contacts and
5.7% (3/53) among family/household contacts.
Of the 130 repeat swabs, two cultured positive
(MenA and MenC, respectively); both origi-
nated from nonfamily/household contacts and
likely represented ongoing community trans-
mission. All identified carriers were younger
than 13 years and asymptomatic; 80% (4/5)
were male.
Malaysia
One study from Malaysia assessed meningo-
coccal carriage. This survey by Rohani and col-
leagues was conducted in June 2005 and
investigated meningococcal carriage in military
recruits during the third month of residence
and intensive training at an army camp [57]. A
total of 3195 healthy recruits aged 17–24 years
were sampled, and both throat and nasal sam-
ples were collected from each recruit. N.
meningitidis was isolated from 1181 subjects,
giving an overall carriage rate of 37.0% (1181/
3195). Among female subjects, 19.7% were car-
riers; among male subjects, 39.2% were carriers.
Of the 1181 strains isolated, 210 were randomly
selected for serotyping and 100 were tested for
antibiotic susceptibility. Of the serotyped
strains, 81.0% were MenX, MenY, or MenZ;
4.7% were MenW; and 3.3% were MenA. The
remaining 11.0% could not be typed due to
autoagglutination (4.7%), lack of reactivity with
the available antisera (5.2%; available antisera
were to serogroups A, B, C, D, W, X, Y, and Z), or
cross-reactivity with the available antisera
(0.9%). Of the isolates examined for antibiotic
susceptibility, all were susceptible to chloram-
phenicol, rifampin, levofloxacin, and cefo-
taxime; 84% were resistant to cotrimoxazole.
Although 12.5% of tested isolates showed
reduced susceptibility to penicillin in the agar
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disc diffusion test, with minimum inhibitory
concentrations (MICs) between 0.023 lg/mL
and 0.064 lg/mL, all isolates still fell within the
susceptible category based on the MIC
of B 0.064 lg/mL.
Nepal
The prevalence of a carriage state for a range of
bacterial respiratory pathogens was evaluated in
school children in Pokhara during 2015 as
reported by Thapa and colleagues [58]. The 204
healthy children younger than 15 years who
were present on the day of sample collection
were enrolled in the study. There were equal
numbers of students from private and govern-
ment schools (n = 102 students each); 52 par-
ticipants from private schools resided in school
hostels and were aged 10–14 years. No partici-
pant had received meningococcal vaccination.
Swabs taken from the posterior pharyngeal wall
and tonsils of each subject were cultured for a
range of bacterial pathogens, including N.
meningitidis. Among the 204 students sampled,
three were N meningitidis carriers, giving an
overall carriage rate of 1.4%. Of these three
carriers, two were aged 5–9 years (carriage rate,
3.7%; 2/54) and the other was aged 10–14 years
(carriage rate, 0.6%; 1/150); all had a history of
repeated throat infection. Antibiotic sensitivity
testing revealed that the three meningococcal
isolates were resistant to penicillin. Serotyping
and molecular characterization of isolates were
not undertaken.
The Philippines
In a cross-sectional meningococcal carriage
study conducted in the Philippines by Gonzales
and colleagues, posterior pharyngeal swabs were
collected between August 2013 and March 2014
from healthy individuals aged 5–24 years [48].
Individuals who had previously received
meningococcal conjugate vaccination were
excluded from the study. Subjects were sampled
across three sites in Manila (1 elementary
school, 1 high school, and 1 university) using a
stratified random sampling method (i.e., school
year was used as the stratum). Subjects were
then stratified into four age groups: 5–9 years,
n = 248; 10–14 years, n = 210; 15–19 years,
n = 232; and 20–24 years, n = 247. Among all
age groups, 43.2% of subjects were male and
97.4% were nonsmokers. Of the 937 subjects,
35 were found to be carriers of N. meningitidis,
giving an overall carriage rate of 3.7% (95% CI:
2.6, 5.2). Of the 35 carriers, 28 carried a single
meningococcal serogroup (MenB, n = 23;
MenC, n = 3; MenY, n = 2), two carried multiple
serogroups (MenY/MenW, n = 1; MenB/MenY/
MenW, n = 1), and five carried strains for which
a capsular serogroup was not identified. Clonal
complex was determined for 31 isolates, the
most common being cc175C, cc41/44C/L3, and
cc5656; 68% of the identified complexes mir-
rored isolates from IMD cases reported in Eur-
ope during 2012. The prevalence of carriage
varied by age and was highest in the 10- to
14-year age group (carriage rate, 9%; 95% CI:
5.5, 13.8; P\0.001). Carriage was also found to
be weakly associated with having a larger
number of siblings (P = 0.08), whereas no sig-
nificant relationship was apparent with sex,
type of living accommodation, smoking, or
number of household inhabitants was apparent.
The authors concluded that individuals aged
10–14 years may play an important part in
meningococcal transmission in the Philippines.
Thailand
A study carried out by Danchiavijitr and col-
leagues during late 1983 and early 1984 assessed
N. meningitidis carriage in children attending
three primary schools in Nakhon Chaisi Dis-
trict, 40 km west of Bangkok [59]. Subjects were
from a medium socioeconomic class and were
likely representative of children living in central
Thailand. Pharyngeal swabs were collected from
843 healthy children aged 5–15 years, 431 of
whom were male. The overall carriage rate was
14.2%. When carriage was assessed according to
age, rates were highest in 14 and 15 year olds;
however, low numbers of subjects of these ages
(n = 12 and n = 1, respectively) limited the rel-
evance of this finding. A total of 94 strains were
tested for antibiotic sensitivity: all were sensi-
tive to chloramphenicol, erythromycin, and
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minocycline; 92 were sensitive and two were
intermediately sensitive to penicillin; four were
resistant to rifampin; and high levels of resis-
tance to sulfadiazine and cotrimoxazole were
apparent (43.6% and 58.5% of strains, respec-
tively). The authors commented that the car-
riage rate observed in the study did not appear
to reflect the very low rate of reported
meningococcal meningitis in Thailand at the
time [59].
DISCUSSION
As demonstrated by our analysis, very limited
published data are available on N. meningitidis
carriage in low and middle income countries of
the Americas and Asia. Of the published data
identified, there was a notable lack of extensive
contemporary information and no standard-
ization of sampling or laboratory methods.
Moreover, the preponderance of data was in
children and adolescents from small popula-
tions, often from limited areas in a specific
country. Many countries in these regions do not
have any published data on meningococcal
carriage.
The overall carriage rate in low and middle
income countries of the Americas ranged from
1.6% [children (2–71 months) and adolescents
(15–19 years) in Mexico City in 2004 to 2005]
[44] to 9.9% (students aged 11–19 years in
Campinas, Brazil in 2012) (Fig. 2) [35]. The
carriage rate among close contacts of IMD
patients following an outbreak was much
higher (21.5%) [38]. In low and middle income
countries of Asia, the carriage rate varied from
1.4% (children aged 5–14 years in 2015 in
Nepal) [58] to 14.2% (children aged 5–15 years
in central Thailand in 1983–1984) (Fig. 3) [59].
In military recruits, the carriage rate ranged
from 11.9% (aged 16–25 years in India) [54] to
37% (aged 17–24 years in Malaysia in 2005)
[57]. There was also an inconsistent rate of car-
riage among contacts of patients with IMD in
Asia, reflecting the diverse populations sam-
pled, ranging from 62.5% for cellmates of
patients with IMD in a Chinese prison [53] to
5.7% among household/family members of
patients in India [56]. Of note, the comparison
of data between countries should be undertaken
with caution because there were notable differ-
ences between studies that could affect results,
including populations assessed, sampling tech-
niques (Tables S2, S3), time periods, and stan-
dard surveillance activities employed in each
country or region. Because of these differences,
we were not able to perform comprehensive
analyses of meningococcal carriage by age in
low and middle income countries of the Amer-
icas and Asia. Future carriage studies that follow
a controlled or structured design are thus criti-
cal for defining carriage characteristics in these
regions and allowing comparisons to high
income countries such as the United Kingdom
[13].
Some of the studies in our review assessed
the antibiotic susceptibility of carriage isolates.
In the study from Nepal, all three isolates were
found to be resistant to penicillin [58]. In con-
trast, studies from Brazil [60], Thailand [59], and
Malaysia [57] found decreased antibiotic sus-
ceptibility of carriage strains. Because of the
small sample size, we have interpreted these
findings with caution. However, further assess-
ment of the antibiotic susceptibility of
meningococci is warranted because of the
potential emergence of resistant strains that
could complicate treatment, particularly in
countries that do not have routine vaccination
programs for primary prevention.
Few studies in our review assessed the effect
of vaccination on carriage, which is also related
to the limited number of countries that have
incorporated meningococcal vaccines in
national immunization programs (Table S1).
Although meningococcal vaccination has led to
a reduction in meningococcal disease [61], the
effect of vaccination on carriage acquisition
depends on the type of vaccine (i.e., polysac-
charide vs. conjugate vaccines) [62]. In our
review, a study from Salvador, Brazil, found a
low rate of MenC carriage isolates in adolescents
and young adults, which was attributed to a
mass MenC vaccination campaign for 10–
24 year olds [34]. Another study compared the
phenotypes of isolates from healthy carriers in
Cuba before and following widespread VA-
MENGOC-BC vaccination; this study found
that MenB isolates predominated in the
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epidemic (i.e., pre-vaccination) period whereas
nonserogroupable isolates became prominent
in the post-vaccination period [47].
Interestingly, studies from Chile found a
high rate of MenW cc11 among disease isolates,
with only a very small percentage, if any, of
carriage isolates attributed to cc11 [40, 41]. The
authors hypothesized that the low carriage of
MenW cc11 in Chile could be attributed to
enhanced virulence of this strain, allowing most
infections to result in disease rather than car-
riage. This finding differs with those from
studies from Burkina Faso [63] and Saudi Arabia
[64], which found a positive correlation of
MenW carriage prevalence and disease inci-
dence. However, it is similar to those from
studies of MenC in the United Kingdom, where
carriage of cc11 was rare, but MenC was an
important cause of disease [18], and studies of
MenA in sub-Saharan Africa, where carriage was
rare, but disease was common [65].
Risk factors associated with carriage were
inconsistently assessed in studies from low and
middle income countries of the Americas and
Asia. In addition, few studies had adequate
power to measure associations because of the
low rates of carriage and the small sample sizes
among subgroups. North American and Euro-
pean studies have found an association between
smoking and carriage [14, 15], and a study from
sub-Saharan Africa found an association
between both passive and active smoking and
carriage, the latter of which was statistically
significant [12]. In comparison, our review
found a significant association of carriage with
passive smoking in only three studies from the
Americas [33, 35, 42] and no significant associ-
ation with active smoking.
A recently published systematic review and
meta-analysis by Peterson and colleagues
investigated serogroup-specific meningococcal
carriage by age group [66]. Eligible carriage
studies were carried out between 2007 and 2016
in healthy populations with defined age groups
and geographical regions. A total of 65 studies
were included in the review. Overall carriage
rates from low and middle income countries of
the Americas and Asia were generally similar to
those identified in the current review. Of the
11 studies included from the Americas region,
seven were set in low and middle income
countries (Brazil, n = 4; Chile, n = 2; and
Colombia, n = 1); with the exception of a study
carried out in Brazilian university students,
which found a carriage rate of 71.1%, the
observed carriage in these studies ranged from
4.0% to 12.6%. Almost all of the 32 studies from
Asia were set in low and middle income coun-
tries (China, n = 29; India, n = 1; the Philip-
pines, n = 1). Overall carriage rates observed in
China varied from 0% to 33.7% and there was
no discernable pattern with regards to year,
province, or age group. The single studies from
India and the Philippines reported rates of 1.5%
and 1.6% to 9.1%, respectively.
It is interesting to consider our findings in
the context of meningococcal carriage data
available from sub-Saharan Africa. In this
region, carriage is highest in children, although
patterns are not always consistent among stud-
ies [67]. In the systematic review by Peterson
and colleagues, carriage in sub-Saharan Africa
ranged from 1.7% in Burkina Faso (individuals
aged 1–29 years) to 13.2% in the Gambia
(individuals aged 10–18 years) [66]. In a meta-
analysis of six of these African studies, the pat-
tern of carriage across age groups was similar for
all serogroups, with a peak consistently
observed in 5–17 year olds. Consistent with
these findings, a longitudinal study of sub-Sa-
haran African countries found the overall car-
riage rate to be 2.4%, with the highest rates in
those 5–14 years of age [12]. This longitudinal
study also found higher risk of meningococcal
acquisition in those reporting a sore throat
during the dry season, smoking tobacco (as
described above), and exposure to wood smoke.
In addition and consistent with our observa-
tions, a clear association between carriage
prevalence and disease from these African data
has not been identified [12, 67]. However, the
introduction of the MenA conjugate vaccine
MenAfriVac resulted in a substantial reduction
in both disease and carriage acquisition [65].
The limitation of our review is the scope of
the literature search, which was restricted to
English-language articles within PubMed,
thereby excluding some non-English language
publications and articles on meningococcal
carriage published in journals not indexed in
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PubMed. Further, any literature published
locally by healthcare authorities or national
surveillance programs (where available) was not
captured by our search strategy. That said, it
should be emphasized that the PubMed litera-
ture search likely included much of the data
available on meningococcal carriage, particu-
larly those from larger and contemporary stud-
ies. One particular limitation of this search
strategy is that the current review includes two
studies from China with only one including
data outside of an outbreak setting [51, 53]. In
contrast, the recently published systematic
review of meningococcal carriage by Peterson
and colleagues described above [66], which
searched several databases (e.g., global health
and Chinese literature databases), did not
exclude any article based on language, and
therefore included 29 studies from China (all of
which were conducted between 2007 and
2016). However, compared with our literature
review, this systematic review did not assess risk
factors for carriage nor did it limit the analysis
to low or middle income countries.
CONCLUSIONS
Future carriage studies in low and middle
income countries of the Americas and Asia
should incorporate larger representative popu-
lations, a wider age range, and additional
countries in these regions. The countries inclu-
ded in our review are typically densely popu-
lated and have extensive socioeconomic,
ethnic, and environmental diversity, suggesting
that the epidemiology and risk factors for
meningococcal carriage may also vary greatly
between countries. Thus, the lack of contem-
porary and comprehensive carriage data in low
and middle income countries of the Americas
and Asia is a major unmet need. Such data, in
combination with high quality disease surveil-
lance, are needed to better elucidate the at-risk
populations for disease and transmission so that
meningococcal vaccine strategies that directly
prevent disease and maximize herd protection
can be developed based on the specific needs
and characteristics of a particular country.
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